(Q35987864)

11 August 2017

1 reference

title

Probiotics and gastrointestinal diseases (English)

1 reference

11 August 2017

0 references

Sullivan A

1

1 reference

PubMed ID

15606379

11 August 2017

Nord CE

series ordinal

2

1 reference

PubMed ID

15606379

11 August 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Journal of Internal Medicine

11 August 2017

1 reference

11 August 2017

257

1 reference

11 August 2017

78-92

1 reference

11 August 2017

1

1 reference

Gut flora in health and disease

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

21 January 2018

Colonization resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Probiotic agents and infectious diseases: a modern perspective on a traditional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Lack of therapeutic effect of a specially designed yogurt for the eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Interactions between rotavirus and gastrointestinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Treatment and prevention of antibiotic associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Epidemiology of Clostridium difficile-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

The role of probiotics and prebiotics in the management of diarrhoea associated with enteral tube feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Probiotics for the treatment of postoperative complications following intestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Saccharomyces boulardii in maintenance treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Probiotics in inflammatory bowel disease: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

Manipulation of the bacterial flora in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2004.01410.X

10.1111/J.1365-2796.2004.01410.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15606379